---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-003336"
form_type: "8-K"
ticker: null
cik: "0001504167"
company_name: "TREX WIND-DOWN, INC."
filed_at: "2024-01-23T23:59:59+00:00"
generated_at: "2026-06-06T19:59:24.189156+00:00"
event_type: "m_and_a"
sentiment: "negative"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# Timber Pharmaceuticals completes asset sale to LEO Pharma for $14.35M in Chapter 11

## Summary
- Bankruptcy Court approved the asset sale on Jan 22, 2024; closing occurred same day.
- Purchase price of $14.35M; $13.9M paid via credit bid of outstanding DIP loan.
- LEO Pharma acquired substantially all assets including TMB-001 under stalking horse agreement.
- CEO John Koconis, CFO Joseph Lucchese, and CMO Alan Mendelsohn resigned; join LEO entity.

## SEC filing metadata
- accession: 0001493152-24-003336
- form_type: 8-K
- cik: 0001504167
- company_name: TREX WIND-DOWN, INC.
- filed_at: 2024-01-23T23:59:59+00:00
- event_type: m_and_a
- sentiment: negative
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 1.01, 2.01, 1.03, 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1504167/000149315224003336/0001493152-24-003336-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1504167/000149315224003336/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-003336
- JSON: https://secwatch.observer/filing/0001493152-24-003336.json
- Plain text: https://secwatch.observer/filing/0001493152-24-003336.txt

## Key facts
- Executive change
  John Koconis resigned as Chief Executive Officer, President and Chairman of the Board at TREX WIND-DOWN, INC..
  - Action: resigned
  - Role: Chief Executive Officer, President and Chairman of the Board
  source text: Effective as of the closing of the Asset Sale, each of John Koconis, Chief Executive Officer, President and Chairman of the Board, and Joseph Lucchese, Chief Financial Officer, Treasurer and Secretary, resigned from their respective executive officer and other employment positions they held with the Company and the Company’s subsidiaries, as applicable, and assumed employment positions with LEO Spiny Merger Sub, Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1504167/000149315224003336/0001493152-24-003336-index.htm
- Executive change
  Joseph Lucchese resigned as Chief Financial Officer, Treasurer and Secretary at TREX WIND-DOWN, INC..
  - Action: resigned
  - Role: Chief Financial Officer, Treasurer and Secretary
  source text: Effective as of the closing of the Asset Sale, each of John Koconis, Chief Executive Officer, President and Chairman of the Board, and Joseph Lucchese, Chief Financial Officer, Treasurer and Secretary, resigned from their respective executive officer and other employment positions they held with the Company and the Company’s subsidiaries, as applicable, and assumed employment positions with LEO Spiny Merger Sub, Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1504167/000149315224003336/0001493152-24-003336-index.htm
- Executive change
  Alan Mendelsohn departed as Chief Medical Officer at TREX WIND-DOWN, INC..
  - Action: no longer serves
  - Role: Chief Medical Officer
  source text: Also effective as of the closing of the Asset Sale, Alan Mendelsohn, Chief Medical Officer, no longer serves as Chief Medical Officer of the Company and any other positions with the Company’s subsidiaries, as applicable and has been offered employment with LEO Spiny Merger Sub, Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1504167/000149315224003336/0001493152-24-003336-index.htm
- M&A Transactions
  TREX WIND-DOWN, INC. completed a disposition involving LEO Pharma A/S for $14.35 million (closed 2024-01-22).
  - Action: disposition
  - Counterparty: LEO Pharma A/S
  - Consideration: $14.35 million
  - Closing: 2024-01-22
  source text: Agreement. the Debtors agreed to sell substantially all of the assets of the Company and its subsidiaries, including TMB-001, to LEO (the “Asset Sale”), for a purchase price of $14.35 million (the “Purchase Price”) plus the assumption of certain liabilities, subject to approval by the Bankruptcy Court and other agreed-upon conditions. On January 22, 2024, the
  evidence_url: https://www.sec.gov/Archives/edgar/data/1504167/000149315224003336/0001493152-24-003336-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.